Additionally, supplementation with AGs resulted in a statistically significant decrease in plasma IL-17A, suggesting a reduction in neutrophilic inflammation, a hallmark of the obese asthma phenotype (Figure 7E). The gene discussed is IL17A; the disease is asthma.